Fig. 2

a-c Kaplan-Meier survival analysis for astrocytic brain tumors patients. a Patients were divided into serum Neudesin^Low and serum Neudesin^High subgroups by using a Neudesin cut-off (=median) value of 1.24 ng/mL. b Patients were divided into CSF Neudesin^Low and CSF Neudesin^High subgroups by using a Neudesin cut-off (=median) value of 1.31 ng/mL. c Patients were divided into Neudesin Quotient^Low and Neudesin Quotient^High subgroups by using a Neudesin cut-off (=median) value of 0.99